Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward commercializationNEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet® device, today announces recent progress on the development of its user-filled spray dispenser. “Millions of consumers have difficulty with traditional eye drops, including difficulty with ...